Dan Yue

1.3k total citations
41 papers, 787 citations indexed

About

Dan Yue is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Dan Yue has authored 41 papers receiving a total of 787 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 8 papers in Pulmonary and Respiratory Medicine and 7 papers in Surgery. Recurrent topics in Dan Yue's work include Ubiquitin and proteasome pathways (5 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Renal and related cancers (4 papers). Dan Yue is often cited by papers focused on Ubiquitin and proteasome pathways (5 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Renal and related cancers (4 papers). Dan Yue collaborates with scholars based in China, United States and Japan. Dan Yue's co-authors include Xun Sun, Ruibing Chen, Yi‐Ting Wang, Hua Geng, Yong Wang, Yajing Chen, Yong Wang, Yong Wang, Jing Su and Yunde Liu and has published in prestigious journals such as Bioresource Technology, Oncogene and Scientific Reports.

In The Last Decade

Dan Yue

37 papers receiving 778 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dan Yue China 19 406 158 147 136 133 41 787
Junlin Yao China 18 541 1.3× 311 2.0× 265 1.8× 47 0.3× 136 1.0× 24 1.1k
Lijun Zhao China 15 430 1.1× 88 0.6× 167 1.1× 49 0.4× 55 0.4× 49 755
Vitalba Ruggieri Italy 17 374 0.9× 65 0.4× 109 0.7× 52 0.4× 54 0.4× 29 650
Sheng‐Hui Lan Taiwan 19 562 1.4× 34 0.2× 143 1.0× 118 0.9× 83 0.6× 38 1.0k
Atıl Bişgin Türkiye 16 318 0.8× 204 1.3× 112 0.8× 59 0.4× 116 0.9× 100 789
Rachel Sexton United States 15 575 1.4× 80 0.5× 247 1.7× 114 0.8× 208 1.6× 30 930
Junhui Yu China 15 400 1.0× 87 0.6× 279 1.9× 157 1.2× 105 0.8× 33 741
Chiao‐Fang Teng Taiwan 21 474 1.2× 165 1.0× 188 1.3× 76 0.6× 54 0.4× 47 1.1k
Yixin Qian China 11 887 2.2× 92 0.6× 532 3.6× 89 0.7× 40 0.3× 29 1.3k

Countries citing papers authored by Dan Yue

Since Specialization
Citations

This map shows the geographic impact of Dan Yue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan Yue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan Yue more than expected).

Fields of papers citing papers by Dan Yue

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dan Yue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan Yue. The network helps show where Dan Yue may publish in the future.

Co-authorship network of co-authors of Dan Yue

This figure shows the co-authorship network connecting the top 25 collaborators of Dan Yue. A scholar is included among the top collaborators of Dan Yue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dan Yue. Dan Yue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dong, Yan, Qun Qiao, Ruibing Chen, et al.. (2025). ABCG1 promotes the proliferation and migration of clear cell renal cell carcinoma and reduces its apoptosis. International Journal of Medical Sciences. 22(11). 2721–2737.
2.
Wang, Hao, Xiao Tong, Hao Zhuang, et al.. (2025). STBD1 mediates the crosstalk between glycogen and lipid droplets in clear cell renal cell carcinoma. Cell Reports. 44(10). 116429–116429.
3.
Zhi, Defu, et al.. (2025). Royal jelly acid alleviates diet-induced hyperlipidemia through regulation of oxidative stress and tryptophan metabolism. European Journal of Pharmacology. 998. 177500–177500. 1 indexed citations
4.
Wang, Rui, Yi‐Ting Wang, Ruibing Chen, et al.. (2023). p32 regulates glycometabolism and TCA cycle to inhibit ccRCC progression via copper-induced DLAT lipoylation oligomerization. International Journal of Biological Sciences. 20(2). 516–536. 9 indexed citations
5.
Liu, Shuang, Xin He, Justin E. Ideozu, et al.. (2022). G3BP1 regulates breast cancer cell proliferation and metastasis by modulating PKCζ. Frontiers in Genetics. 13. 1034889–1034889. 4 indexed citations
6.
Wang, Yi‐Ting, Shuang Liu, Rui Wang, et al.. (2022). C1QBP regulates apoptosis of renal cell carcinoma via modulating xanthine dehydrogenase (XDH) mediated ROS generation. International Journal of Medical Sciences. 19(5). 842–857. 10 indexed citations
7.
Wang, Chao, Qiqi Cui, Shuang Liu, et al.. (2021). Expression of G3BP1 in benign and malignant human prostate tissues. Translational Andrology and Urology. 10(4). 1665–1675. 9 indexed citations
8.
Ma, Jinhu, Chunxue Zhang, Gang Shi, et al.. (2021). High-dose VitC plus oncolytic adenoviruses enhance immunogenic tumor cell death and reprogram tumor immune microenvironment. Molecular Therapy. 30(2). 644–661. 21 indexed citations
9.
Wang, Yong, Jing Su, Yi‐Ting Wang, et al.. (2018). The Role of YB1 in Renal Cell Carcinoma Cell Adhesion. International Journal of Medical Sciences. 15(12). 1304–1311. 18 indexed citations
10.
Yue, Dan, Yong Wang, Yin Sun, Yuanjie Niu, & Chawnshang Chang. (2017). C1QBP Regulates YBX1 to Suppress the Androgen Receptor (AR)-Enhanced RCC Cell Invasion. Neoplasia. 19(2). 135–144. 20 indexed citations
11.
Wang, Yong, Jing Su, Yajing Chen, et al.. (2017). C1QBP suppresses cell adhesion and metastasis of renal carcinoma cells. Scientific Reports. 7(1). 999–999. 23 indexed citations
12.
Wang, Yuanyuan, Xuefeng Jiang, Junfeng Zhu, et al.. (2016). IL-21/IL-21R signaling suppresses intestinal inflammation induced by DSS through regulation of Th responses in lamina propria in mice. Scientific Reports. 6(1). 31881–31881. 31 indexed citations
13.
Zhu, Junfeng, Li-Xuan Sang, Jingbo Zhai, et al.. (2015). IL‐33 Aggravates DSS‐Induced Acute Colitis in Mouse Colon Lamina Propria by Enhancing Th2 Cell Responses. Mediators of Inflammation. 2015(1). 913041–913041. 35 indexed citations
14.
Chen, Liang, Shuai Xu, Yongming Xu, et al.. (2015). Cab45S promotes cell proliferation through SERCA2b inhibition and Ca2+ signaling. Oncogene. 35(1). 35–46. 24 indexed citations
15.
Wang, Yong, et al.. (2015). Overexpression of YB1 and EZH2 are associated with cancer metastasis and poor prognosis in renal cell carcinomas. Tumor Biology. 36(9). 7159–7166. 40 indexed citations
16.
Yue, Dan, Ya-Fei Xu, Fan Zhang, et al.. (2014). Is replacement of the supraclavicular fossa with the lower level classification based on magnetic resonance imaging beneficial in nasopharyngeal carcinoma?. Radiotherapy and Oncology. 113(1). 108–114. 22 indexed citations
17.
Song, Jiayin, Yong Wang, Xue Li, et al.. (2013). Critical role of TRPC6 channels in the development of human renal cell carcinoma. Molecular Biology Reports. 40(8). 5115–5122. 31 indexed citations
18.
Yue, Dan, et al.. (2012). Effects of bortezomib in sensitizing human prostate cancer cell lines to NK-mediated cytotoxicity. Asian Journal of Andrology. 14(5). 695–702. 8 indexed citations
19.
Wang, Yong, et al.. (2010). The role of TRPC6 in HGF-induced cell proliferation of human prostate cancer DU145 and PC3 cells. Asian Journal of Andrology. 12(6). 841–852. 41 indexed citations
20.
Yue, Dan, et al.. (2010). Effects of transferred NK4 gene on proliferation, migration, invasion and apoptosis of human prostate cancer DU145 cells. Asian Journal of Andrology. 12(3). 381–389. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026